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Abstract We have previously shown that the methyl ester of
hepoxilin A3 causes a receptor-induced rise in intracellular
calcium through the release from intracellular stores in
suspended human neutrophils. The corresponding free acid was
devoid of activity. We now report that the action of the free acid
form of hepoxilin A3 is dependent on the type of vehicle used, i.e.
it is active in releasing calcium when used in an ethanol vehicle
but not in DMSO. The methyl ester is equally active in either
vehicle. The pattern of calcium release between the free acid and
the methyl ester is qualitatively different. Both compounds show
a biphasic pattern, i.e. an initial rapid phase followed by a slow
decline in calcium levels but never reaching pre-hepoxilin A3
baseline levels. The methyl ester appears slightly more potent in
the initial phase of calcium release than the free acid
(methyl = 188 þ 14 S.D., free acid = 135 þ 11 S.D. nM,
P6 0.0005). Both compounds appear to reach the same calcium
levels at the plateau of the second prolonged phase
(methyl = 88 þ 8 S.D., free acid = 107 þ 15 S.D. nM, not
significant). Lanthanum chloride (an inhibitor of calcium influx)
interfered with the second phase of the curve causing calcium
levels to return to normal pre-hepoxilin levels for both
compounds. Addition of lanthanum chloride prior to the
hepoxilin addition or carrying out the experiments in calcium-
free medium, eliminated the second phase completely, with the
calcium peak returning rapidly to normal baseline levels,
suggesting that the second phase is due to calcium influx. Again
the methyl ester is more active than the free acid (methyl,
189 þ 12; free acid, 145 þ 6 S.D. nM, P6 0.005). Additional
experiments with tritium-labelled methyl ester of hepoxilin A3
demonstrated that the compound is hydrolyzed into the free acid
intracellularly. These experiments demonstrate that DMSO
interacts with hepoxilin free acid, interfering with its entry into
the cell while ethanol does not. Once inside the cell, hepoxilin
interacts with its own receptor to release calcium rapidly from
stores, but it also causes a more prolonged influx of calcium from
the extracellular milieu.
z 1999 Federation of European Biochemical Societies.
1. Introduction
We have recently shown that hepoxilin (Hx) A3 interacts
with a speci¢c binding protein in the intact human neutrophil
resulting in the release of intracellular calcium [1]. In those
studies we used the methyl (Me) ester form in DMSO because
we found that the free acid (FA) was without e¡ect in intact
cells both in terms of binding and calcium release [2]. We also
found that both the FA and Me ester (in DMSO) were active
in speci¢c binding to disrupted neutrophil membranes [3].
This suggested that the FA did not penetrate into the intact
cell and that the binding protein was intracellular and not at
the outside surface of the plasma membrane. We now describe
new ¢ndings which support a binding/calcium release coupling
where both the FA and the Me ester are found active (in
ethanol vehicle) in the intact neutrophil and demonstrate a
biphasic action of HxA3, one in releasing calcium from intra-
cellular stores, a second in increasing calcium in£ux.
2. Materials and methods
2.1. Materials
Pure 8(R)-HxA3 Me ester was prepared in our laboratory as pre-
viously reported [4]. The FA was prepared by hydrolysis of the Me
ester with 1 N KOH/ethanol followed by mild acidi¢cation, extraction
and further puri¢cation by chromatography [5]. [3H6](8R)-HxA3 Me
ester was prepared as previously reported [5]. Lanthanum chloride
was purchased from Sigma (St. Louis, MO, USA).
2.2. Preparation of human neutrophils
Human neutrophils were prepared essentially as described previ-
ously [3]. Typically, neutrophils were obtained from 40 ml venous
blood from volunteers that had not taken any medication. The blood
was anti-coagulated with heparin sodium (Organon Tecknica, Dur-
ham, NC, USA). Erythrocytes were removed by 4.5% dextran sedi-
mentation. Neutrophils were collected and pelleted after Ficoll-Paque
gradient centrifugation. Further removal of contaminating erythro-
cytes was carried out by ammonium chloride lysis. After washing
twice with centrifugation, neutrophils were resuspended in RPMI
1640 medium and were counted in a Coulter counter (Model 901).
The cells were adjusted to a concentration of 107 cells/ml in RPMI
1640 medium.
2.3. Intracellular calcium release
Freshly prepared neutrophil suspensions (1 ml: 1U107 cells) were
loaded with 3 mM (¢nal concentration 3 WM) of the acetoxymethyl
ester precursor of the calcium indicator (Indo-1-AM, Calbiochem, La
Jolla, CA, USA) during 30 min at 37‡C. Excess dye was removed by
centrifugation and the cells were suspended in fresh RPMI 1640 me-
dium. Dye-loaded cells were kept at room temperature on a rotator.
Each measurement consisted of the following: 2U106 cells were sus-
pended in 1 ml of assay medium of the following composition in mM:
NaCl 140, KCl 5, MgCl2 1, CaCl2 1, HEPES sodium-free 10 and
glucose 10, pH 7.3 and placed in a plastic cuvette (Diamed Lab.,
Toronto, Canada) whose temperature was controlled at 37‡C. Calci-
um-free media contained no calcium and 1 mM EGTA was added.
The cell suspension was continuously stirred magnetically. Fluores-
cence was continuously monitored with a Perkin-Elmer £uorescence
spectrophotometer (model 650-40) and recorded on a chart recorder
(LKB model 2210) set at 1 cm/min. The excitation wavelength was set
at 331 nm, the emission wavelength at 410 nm, with slits of excitation
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and emission set at 3 and 15 nm respectively. At the end of each test,
a calibration was carried out to determine the maximal £uorescence
by adding ionomycin (Sigma) at 1 mM (¢nal concentration 1 WM) and
minimal £uorescence by adding MnCl2 (¢nal concentration 3 mM) as
previously described [6]. Test compounds were prepared in DMSO
(Caledon, Georgetown, OR, USA) or glass-distilled ethanol (100%)
at a stock solution of 1 Wg/Wl or 5 Wg/Wl and 1 Wl of this solution was
added to 2U106 cells in 1 ml.
2.4. Metabolism of [3H6]HxA3 Me ester
Freshly prepared human neutrophils were incubated in the above
assay medium in a siliconized glass tube to which had been added
[3H](8R)-HxA3 Me ester (5U106 cpm) diluted with 3 Wg of the un-
labelled compound. The mixture was incubated for 1 or 5 minutes and
the incubation mixture was extracted with ethyl acetate without prior
acidi¢cation to extract the intact Hx structure and its products (which
are acid sensitive). The solvent was evaporated to dryness with N2 gas
and the residue was dissolved in a small amount of ethyl acetate and
spotted on TLC (silica gel G, ethyl acetate/acetic acid 99.5/0.5 (v/v)).
The plate was developed for 60 min, then the solvent was dried with
cold air and scanned for radioactivity on a TLC radiochromatogram
scanner (Berthold). Authentic standards of HxA3 Me ester and FA as
well as the g-hydroxy (gH) metabolite FA (product of g-oxidation
[7]) and the trihydroxy metabolite FA (product of epoxide hydrolase)
were spotted as reference compounds.
3. Results and discussion
We show herein that HxA3 FA but not the Me ester is
vehicle sensitive in evoking a rise in intracellular calcium in
suspensions of human neutrophils. Fig. 1A shows a typical
pattern of intracellular calcium resulting from the addition
of HxA3 Me ester (upper trace) and FA (lower trace) in
DMSO as vehicle. This is compared with the same two com-
pounds added in ethanol as vehicle (Fig. 1B). The following
three points are apparent. First, the pattern for the Me ester is
similar and independent of the vehicle used (compare upper
traces in Fig. 1A and B). Second, the FA is inactive when
made up in DMSO but is active when added in ethanol ve-
hicle (compare lower traces in Fig. 1A and B). Third, both
compounds added in ethanol show a rapid action (rise in
intracellular calcium) and a slower more prolonged decrease
in calcium levels but never decreasing to pre-HxA3 levels (see
Fig. 1B). The Me ester appears more potent in the rapid initial
phase of calcium release than the FA (Me, 188 þ 14 S.D.; FA,
135 þ 11 S.D. nM, P6 0.0005, n = 3) and decreases to a sim-
ilar plateau level as with the FA (Me, 88 þ 8 S.D.; FA,
107 þ 15 S.D. nM, not signi¢cant, n = 3). Hence, the decrease
to the second phase (prolonged calcium rise) is greater with
the Me ester (from 188 to 88 nM = 53%) than with the FA
(from 135 to 107 nM = 20%). In order to address this second
phase of calcium ‘retention’, we administered lanthanum
chloride (1 WM ¢nal concentration) at the plateau of the pro-
¢le (about 5 min after the addition of HxA3). Lanthanum
chloride blocks the entry of calcium by inhibiting calcium
channels [8,9]. Lanthanum caused an immediate decrease in
intracellular calcium levels towards the baseline for both the
Me ester as well as the FA (Fig. 1B, upper and lower traces).
In separate experiments (Fig. 1C) carried out in medium de-
void of extracellular calcium (containing EGTA), the Me ester
(tested in DMSO or ethanol) e¡ected the same rapid initial
phase of intracellular calcium rise but the peak response
quickly returned to baseline (Fig. 1C, upper trace), suggesting
that the second (longer) phase of the normal HxA3 response
was due to the entry of extracellular calcium. Similar results
were observed with the FA of HxA3 (Fig. 1C, lower trace).
Again the Me ester is slightly more potent than the FA (Me,
189 þ 12 S.D.; FA, 145 þ 6 S.D. nM, P6 0.005, n = 3). Similar
results to the extracellular calcium-free experiments were ob-
served when lanthanum chloride was added to the cells prior
to HxA3 (data not shown).
In order to investigate further whether the calcium releasing
action of HxA3 on neutrophils was mediated via its conver-
sion into other compounds, we incubated tritiated HxA3 Me
ester with human neutrophils and analyzed the products after
1 and 5 min incubation, the periods of maximal change in
intracellular calcium. The ethyl acetate extract of the incuba-
tion was analyzed by TLC. Fig. 2 shows that within a 1 min
incubation (the period of sharp initial calcium rise) the Me
ester is only partially hydrolyzed (about 10%) into the FA by
intracellular esterases, demonstrating that the Me ester pene-
trates into the cell where it acts to release calcium from cal-
cium stores (rapid initial phase). About 50% of the Me ester is
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Fig. 1. Fluorescence pro¢les of intracellular calcium changes in sus-
pended human neutrophils after administration of HxA3 as the Me
ester or FA prepared and administered in 1 Wl of DMSO (Fig. 1A)
or ethanol (Fig. 1B, C) as vehicles. Note that the FA is inactive in
DMSO even at 5U the dose of the Me ester (Fig. 1A, bottom).
The e¡ect of lanthanum chloride (1 WM) is shown (Fig. 1B). Fig.
1C shows the patterns observed in calcium-free medium. Note the
absence of the prolonged second phase (Fig. 1C): this is due to the
in£ux of calcium (in Fig. 1A, B). When lanthanum chloride was
added prior to HxA3 in normal calcium, pro¢les similar to those
observed in Fig. 1C were obtained, con¢rming that the second
phase is due to calcium in£ux.
Fig. 2. TLC radioactivity pro¢les of ethyl acetate extracts of neutro-
phil ‘short’ incubations with [3H6]HxA3 Me ester for various times
indicated. Conditions are essentially similar to the biological assays
shown in Fig. 1. Migration of authentic standards is shown. Note
that within the time frame of biological action (1 min, see Fig. 1),
HxA3 Me is largely unchanged. The FA begins to appear around
this time. Compare the calcium actions between the Me and the FA
(Fig. 1B) with the metabolism pro¢les (Fig. 2). Also note that the
gH metabolite is not formed within this time frame, it is formed
during longer incubations [7].
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converted into the FA as the sole metabolite within 5 min of
incubation. Hence, the rapid initial phase of the calcium pro-
¢le of the Me ester of HxA3 is due to a large part to the Me
ester form itself while the prolonged phase occurs during and
subsequent to the formation of the FA. The important experi-
ment in Fig. 1C (bottom trace) demonstrates that the FA is
also active on intracellular stores to cause the release of intra-
cellular calcium, i.e. it has dual actions.
These experiments demonstrate that HxA3, both as the FA
as well as the Me ester, are taken up into the cell and act to
release calcium from intracellular stores. Within the time
frame of initial action (rapid phase, 1 min), studies with tri-
tiated HxA3 show that the Me ester is not substantially hydro-
lyzed into the FA, although this takes place subsequently and
is likely involved in calcium in£ux. Supporting this is the
¢nding that the second phase of calcium response is equally
pronounced when the FA is used (Fig. 1B) and is absent in
calcium-free medium (Fig. 1C). Finally, caution should be
exerted in the choice of vehicle as we show that DMSO inter-
acts with the FA form of HxA3 (likely through formation of a
polar hydrogen-bonded DMSO-HxA3 adduct [10]) making
the adduct incapable of entering the cell and rendering
HxA3 inactive. In ethanol as vehicle, the FA enters the cell
where it is capable both of releasing calcium from intracellular
stores (see Fig. 1C) and causing in£ux of extracellular calcium
(compare Fig. 1B and C). Similar ¢ndings were observed with
Hx binding studies. The FA dissolved in DMSO did not bind
to intact neutrophils but did bind to membranes from dis-
rupted cells, while the Me ester was equally well bound to
the intact cell as well as disrupted cells [3].
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